-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xeruborbactam in Pseudomonas aeruginosa Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Xeruborbactam in Pseudomonas aeruginosa Infections Drug Details: Xeruborbactam is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xeruborbactam in Acinetobacter Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Xeruborbactam in Acinetobacter Infections Drug Details: Xeruborbactam is under development for the treatment of carbapenem-resistant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oravance in Gram-Negative Bacterial Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oravance in Gram-Negative Bacterial Infections report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xeruborbactam in Enterobacteriaceae Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Xeruborbactam in Enterobacteriaceae Infections Drug Details: Xeruborbactam is under development for the treatment of carbapenem-resistant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DP-303c in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DP-303c in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Gastric Cancer Drug Details:DP-303c is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Multikine in Cervical Intraepithelial Neoplasia (CIN)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Multikine in Cervical Intraepithelial Neoplasia (CIN) Drug Details: Multikine (Leukocyte Interleukin) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Odetiglucan in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Odetiglucan in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Odetiglucan in Follicular Lymphoma Drug Details: BTH-1677 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – QPX-2015
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry QPX-2015 Drug Details QPX-2015 along with beta-lactamse inhibitor is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OMNIvance
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry OMNIvance Drug Details OMNIvance is under development for the treatment of carbapenem-resistant infectious diseases...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ORAvance
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ORAvance Drug Details ORAvance is under development for the treatment of multi drug resistant...